Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €78.35 EUR
Change Today +0.95 / 1.23%
Volume 706.3K
FME On Other Exchanges
New York
As of 2:25 PM 07/28/15 All times are local (Market data is delayed by at least 15 minutes).

fresenius medical care ag & (FME) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/14/15 - €82.32
52 Week Low
07/28/14 - €49.55
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for FRESENIUS MEDICAL CARE AG & (FME)

Related News

No related news articles were found.

fresenius medical care ag & (FME) Related Businessweek News

No Related Businessweek News Found

fresenius medical care ag & (FME) Details

Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, provides dialysis care services related to the dialysis treatment a patient receives with end stage renal disease (ESRD); and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of 3,361 outpatient dialysis clinics in approximately 45 countries worldwide; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure. The company also provides pharmacy services, such as delivery and supply of renal medications to patients at homes or to dialysis clinics directly; vascular, cardiovascular, and endovascular specialty services; and offers products for the treatment of ESRD. In addition, it offers laboratory services that include blood, urine, and other bodily fluid testing services; and hemodialysis (HD) machines, modular components for dialysis machines, polysulfone dialyzers, bloodlines, HD solutions and concentrates, needles, connectors, machines for water treatment, data administration systems, dialysis chairs, phosphate binders, iron products, and other renal drug products. Further, the company provides peritoneal dialysis systems and solutions for continuous ambulatory peritoneal dialysis and automated peritoneal dialysis; and adsorbers, which are filters used in other extracorporeal therapies; and distributes specific instruments for vascular access, as well as other supplies, such as bandages, clamps, and injections. The company sells its products to clinics, hospitals, and specialized treatment clinics through local sales forces, independent distributors, dealers, and sales agents. The company was founded in 1996 and is headquartered in Bad Homburg, Germany.

101,543 Employees
Last Reported Date: 04/30/15
Founded in 1996

fresenius medical care ag & (FME) Top Compensated Officers

Chairman of the Management Board for Freseniu...
Total Annual Compensation: $2.2M
Chief Financial Officer of Fresenius Medical ...
Total Annual Compensation: $1.3M
Chief Executive Officer of Fresenius Medical ...
Total Annual Compensation: $1.5M
Chief Executive Officer of Asia Pacific Divis...
Total Annual Compensation: $1.2M
Chief Executive Officer of Global Manufacturi...
Total Annual Compensation: $931.0K
Compensation as of Fiscal Year 2014.

fresenius medical care ag & (FME) Key Developments

Fresenius Medical Care Provides Earnings Guidance for the Full Year of 2015 and 2016

Fresenius Medical Care provided earnings guidance for the full year of 2015 and 2016. For the year 2015, the company announced that revenue is expected to increase by 10% to 12% in constant currency and net income by up to 5%. For the year 2016, the company expects net income to grow by 15% to 20%, and revenue to increase by 9% to 12% in constant currency.

Fresenius Medical Care AG & Co. KGAA Launches multiFiltratePRO

Fresenius Medical Care AG & Co. KGaA has launched multiFiltratePRO, a therapy system for continuous renal replacement therapy, or CRRT, which is indicated for the treatment of acute kidney failure in critically ill patients at intensive care units.

Fresenius Medical Care AG & Co. KGAA - Shareholder/Analyst Call

Annual general meeting


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FME:GR €78.35 EUR +0.95

FME Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Baxter International Inc $38.00 USD +0.30
Becton Dickinson and Co $149.39 USD +3.06
DaVita HealthCare Partners Inc $78.96 USD +0.53
Mylan NV $55.80 USD -0.57
Toray Industries Inc ¥962.90 JPY -11.40
View Industry Companies

Industry Analysis


Industry Average

Valuation FME Industry Range
Price/Earnings 24.8x
Price/Sales 1.6x
Price/Book 2.7x
Price/Cash Flow 25.5x
TEV/Sales 0.9x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FRESENIUS MEDICAL CARE AG &, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at